Recently, Sino Biopharm was named to the "Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2024" list, released by the well-known pharmaceutical industry media outlet Healthcare Executive, for the third consecutive year. It also won the "Climate Change Response 2024 Top 10 in Climate Change Mitigation (PRC Pharmaceutical Listed Companies)" award for its leading practices in the low-carbon field.